Central Pharmaceuticals Ltd. announced unaudited earnings results for the first quarter ended September 2017. For the quarter, the company reported EPS was BDT 0.14 as against BDT 0.13 for July-September, 2016. NOCFPS was BDT 0.02 for July-September, 2017 as against BDT 0.01 for July-September, 2016. NAV per share was BDT 16.93 as on September 30, 2017 and BDT 16.78 as on June 30, 2017.